目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 44)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
TABLE 1 IMMUNOHISTOCHEMISTRY MARKET: INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 50)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 BREAKDOWN OF PRIMARIES: IHC MARKET
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 3 IHC MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS) 2020
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2020
2.2.1 INSIGHTS FROM PRIMARY EXPERTS
FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 6 IHC MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
FIGURE 7 IHC MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS
2.4 DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 RESEARCH ASSUMPTIONS
2.5.1 COVID-19 SPECIFIC ASSUMPTIONS
2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 61)
FIGURE 9 IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 10 IMMUNOHISTOCHEMISTRY MARKET SHARE, BY APPLICATION, 2020
FIGURE 11 IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021−2026
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF IMMUNOHISTOCHEMISTRY MARKET

4 PREMIUM INSIGHTS (Page No. - 64)
4.1 IMMUNOHISTOCHEMISTRY MARKET OVERVIEW
FIGURE 13 TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET SHARE, BY END USER AND COUNTRY (2020)
FIGURE 14 HOSPITALS & DIAGNOSTIC LABORATORIES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC IHC MARKET IN 2020
4.3 IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE
FIGURE 15 PRIMARY ANTIBODIES SEGMENT TO LEAD IHC ANTIBODIES MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 66)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 IHC MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 2 IHC MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases
TABLE 3 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION (2019-2050)
FIGURE 17 CANCER INCIDENCE, BY REGION AND TYPE OF CANCER, 2020
5.2.1.2 Technological advancements in IHC
5.2.1.3 Availability of reimbursements for IHC tests
TABLE 4 CPT CODES FOR IHC PROCEDURES
5.2.2 RESTRAINTS
5.2.2.1 High degree of consolidation
TABLE 5 MAJOR ACQUISITIONS IN THE MARKET, 2018-2021
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing demand for personalized medicine
5.2.3.2 Growing significance of companion diagnostics
5.2.3.3 Growth opportunities in emerging countries
5.2.4 CHALLENGES
5.2.4.1 Dearth of skilled professionals
TABLE 6 NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 2018
5.2.4.2 Product failures and recalls
5.3 RANGES/SCENARIO
FIGURE 18 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF IHC MARKET
5.4 IMPACT OF COVID-19 OUTBREAK ON IHC MARKET
FIGURE 19 IHC MARKET SCENARIO WITH AND WITHOUT COVID-19 IMPACT, 2019-2021
5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
FIGURE 20 REVENUE SHIFT & NEW POCKET FOR IHC PROVIDERS
5.6 PRICING ANALYSIS
TABLE 7 AVERAGE SELLING PRICE OF SOME IHC EQUIPMENT, REAGENTS, AND KITS (2020)
5.7 VALUE CHAIN ANALYSIS
FIGURE 21 VALUE CHAIN ANALYSIS OF IHC MARKET: RAW MATERIAL AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE
5.8 ECOSYSTEM ANALYSIS
FIGURE 22 ECOSYSTEM ANALYSIS: IHC MARKET
TABLE 8 SUPPLY CHAIN ECOSYSTEM
5.9 TECHNOLOGY ANALYSIS
5.10 PATENT ANALYSIS
FIGURE 23 PATENT GRANTED FOR IHC IN LAST 10 YEARS
TABLE 9 INDICATIVE LIST OF PATENTS IN IHC MARKET
5.11 REGULATORY ANALYSIS
5.11.1 US
TABLE 10 US: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
FIGURE 24 US: REGULATORY PROCESS FOR IVD DEVICES
5.11.2 CANADA
FIGURE 25 CANADA: REGULATORY PROCESS FOR IVD DEVICES
5.11.3 EUROPE
TABLE 11 EUROPE: CLASSIFICATION OF IVD DEVICES
FIGURE 26 EUROPE: REGULATORY PROCESS FOR IVD DEVICES
5.11.4 JAPAN
FIGURE 27 JAPAN: REGULATORY PROCESS FOR IVD DEVICES
TABLE 12 JAPAN: CLASSIFICATION OF IVD REAGENTS
TABLE 13 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.11.5 CHINA
TABLE 14 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.11.6 INDIA
FIGURE 28 INDIA: REGULATORY PROCESS FOR IVD DEVICES
5.11.7 BRAZIL
FIGURE 29 BRAZIL: REGULATORY PROCESS FOR IVD DEVICES
5.12 PORTER’S FIVE FORCES ANALYSIS
TABLE 15 IHC MARKET: PORTER’S FIVE FORCES ANALYSIS
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTES
5.12.3 BARGAINING POWER OF BUYERS
5.12.4 BARGAINING POWER OF SUPPLIERS
5.12.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS

6 IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT (Page No. - 94)
6.1 INTRODUCTION
TABLE 16 IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
6.2 ANTIBODIES
TABLE 17 IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY REGION, 2019-2026 (USD MILLION)
TABLE 18 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 19 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 20 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 21 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY REGION, 2019-2026 (USD MILLION)
TABLE 22 IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
6.2.1 PRIMARY ANTIBODIES
6.2.1.1 Wide applications in diagnostics and research to support demand for primary antibodies
TABLE 23 IMMUNOHISTOCHEMISTRY MARKET FOR PRIMARY ANTIBODIES, BY REGION, 2019-2026 (USD MILLION)
TABLE 24 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR PRIMARY ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 25 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR PRIMARY ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 26 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR PRIMARY ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 27 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR PRIMARY ANTIBODIES, BY REGION, 2019-2026 (USD MILLION)
6.2.2 SECONDARY ANTIBODIES
6.2.2.1 Signal amplification through conjugation and comparatively easy manufacturing to drive market for secondary antibodies
TABLE 28 IMMUNOHISTOCHEMISTRY MARKET FOR SECONDARY ANTIBODIES, BY REGION, 2019-2026 (USD MILLION)
TABLE 29 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR SECONDARY ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 30 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR SECONDARY ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 31 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR SECONDARY ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 32 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR SECONDARY ANTIBODIES, BY REGION, 2019-2026 (USD MILLION)
6.3 REAGENTS
TABLE 33 IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY REGION, 2019-2026 (USD MILLION)
TABLE 34 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 35 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 36 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 37 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY REGION, 2019-2026 (USD MILLION)
TABLE 38 IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
6.3.1 HISTOLOGICAL STAINS
6.3.1.1 Developments in concurrent detection of multiple antigenic sites within single tissue specimen and cancer disease progression studies to propel market growth
TABLE 39 IMMUNOHISTOCHEMISTRY MARKET FOR HISTOLOGICAL STAINS, BY REGION, 2019-2026 (USD MILLION)
TABLE 40 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR HISTOLOGICAL STAINS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 41 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR HISTOLOGICAL STAINS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 42 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR HISTOLOGICAL STAINS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 43 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR HISTOLOGICAL STAINS, BY REGION, 2019-2026 (USD MILLION)
6.3.2 BLOCKING SERA AND REAGENTS
6.3.2.1 Blocking sera and reagents prevent nonspecific binding and reduce background noise and potentially false-positive results
TABLE 44 IMMUNOHISTOCHEMISTRY MARKET FOR BLOCKING SERA AND REAGENTS, BY REGION, 2019-2026 (USD MILLION)
TABLE 45 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR BLOCKING SERA AND REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 46 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR BLOCKING SERA AND REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 47 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR BLOCKING SERA AND REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 48 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR BLOCKING SERA AND REAGENTS, BY REGION, 2019-2026 (USD MILLION)
6.3.3 CHROMOGENIC SUBSTRATES
6.3.3.1 Chromogenic substrates segment to register highest growth during forecast period
TABLE 49 IMMUNOHISTOCHEMISTRY MARKET FOR CHROMOGENIC SUBSTRATES, BY REGION, 2019-2026 (USD MILLION)
TABLE 50 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR CHROMOGENIC SUBSTRATES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 51 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR CHROMOGENIC SUBSTRATES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 52 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR CHROMOGENIC SUBSTRATES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 53 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR CHROMOGENIC SUBSTRATES, BY REGION, 2019-2026 (USD MILLION)

6.3.4 FIXATION REAGENTS
6.3.4.1 North America is largest market for fixation reagents
TABLE 54 IMMUNOHISTOCHEMISTRY MARKET FOR FIXATION REAGENTS, BY REGION, 2019-2026 (USD MILLION)
TABLE 55 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR FIXATION REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 56 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR FIXATION REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 57 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR FIXATION REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 58 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR FIXATION REAGENTS, BY REGION, 2019-2026 (USD MILLION)
6.3.5 DILUENTS
6.3.5.1 Diluents are used to prepare antibody solutions
TABLE 59 IMMUNOHISTOCHEMISTRY MARKET FOR DILUENTS, BY REGION, 2019-2026 (USD MILLION)
TABLE 60 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR DILUENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 61 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR DILUENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 62 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR DILUENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 63 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR DILUENTS, BY REGION, 2019-2026 (USD MILLION)
6.3.6 ORGANIC SOLVENTS
6.3.6.1 Organic solvents prevent physical damage in specimens and improve clarity while visualizing tissue samples
TABLE 64 IMMUNOHISTOCHEMISTRY MARKET FOR ORGANIC SOLVENTS, BY REGION, 2019-2026 (USD MILLION)
TABLE 65 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR ORGANIC SOLVENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 66 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR ORGANIC SOLVENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 67 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR ORGANIC SOLVENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 68 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR ORGANIC SOLVENTS, BY REGION, 2019-2026 (USD MILLION)
6.3.7 PROTEOLYTIC ENZYMES
6.3.7.1 Proteolytic enzymes improve accessibility of target antibodies
TABLE 69 IMMUNOHISTOCHEMISTRY MARKET FOR PROTEOLYTIC ENZYMES, BY REGION, 2019-2026 (USD MILLION)
TABLE 70 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR PROTEOLYTIC ENZYMES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 71 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR PROTEOLYTIC ENZYMES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 72 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR PROTEOLYTIC ENZYMES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 73 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR PROTEOLYTIC ENZYMES, BY REGION, 2019-2026 (USD MILLION)
6.3.8 OTHER REAGENTS
6.3.8.1 Other reagents include antigen retrieval solutions, stabilizers, controls, and mounting solutions
TABLE 74 IMMUNOHISTOCHEMISTRY MARKET FOR OTHER REAGENTS, BY REGION, 2019-2026 (USD MILLION)
TABLE 75 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 76 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 77 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 78 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER REAGENTS, BY REGION, 2019-2026 (USD MILLION)
6.4 EQUIPMENT
TABLE 79 IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY REGION, 2019-2026 (USD MILLION)
TABLE 80 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 81 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 82 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 83 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY REGION, 2019-2026 (USD MILLION)
TABLE 84 IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
6.4.1 SLIDE-STAINING SYSTEMS
6.4.1.1 Development of high throughput staining systems to drive market growth
TABLE 85 IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE-STAINING SYSTEMS, BY REGION, 2019-2026 (USD MILLION)
TABLE 86 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE-STAINING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 87 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE-STAINING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 88 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE-STAINING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 89 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE-STAINING SYSTEMS, BY REGION, 2019-2026 (USD MILLION)
6.4.2 TISSUE PROCESSING SYSTEMS
6.4.2.1 Technological advancements and need for automation due to shortage of skilled workforce to drive market growth
TABLE 90 IMMUNOHISTOCHEMISTRY MARKET FOR TISSUE PROCESSING SYSTEMS, BY REGION, 2019-2026 (USD MILLION)
TABLE 91 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 92 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 93 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 94 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR TISSUE PROCESSING SYSTEMS, BY REGION, 2019-2026 (USD MILLION)
6.4.3 SLIDE SCANNERS
6.4.3.1 Development of advanced multiplexed IHC scanners to drive market growth
TABLE 95 IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE SCANNERS, BY REGION, 2019-2026 (USD MILLION)
TABLE 96 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE SCANNERS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 97 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE SCANNERS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 98 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE SCANNERS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 99 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE SCANNERS, BY REGION, 2019-2026 (USD MILLION)
6.4.4 OTHER EQUIPMENT
TABLE 100 IMMUNOHISTOCHEMISTRY MARKET FOR OTHER EQUIPMENT, BY REGION, 2019-2026 (USD MILLION)
TABLE 101 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 102 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 103 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 104 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER EQUIPMENT, BY REGION, 2019-2026 (USD MILLION)
6.5 KITS
TABLE 105 IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY REGION, 2019-2026 (USD MILLION)
TABLE 106 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 107 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 108 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 109 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY REGION, 2019-2026 (USD MILLION)
TABLE 110 IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY TYPE, 2019-2026 (USD MILLION)
6.5.1 HUMAN IMMUNOHISTOCHEMISTRY KITS
6.5.1.1 Increasing focus on cancer research to fuel market growth
TABLE 111 IMMUNOHISTOCHEMISTRY MARKET FOR HUMAN IMMUNOHISTOCHEMISTRY KITS, BY REGION, 2019-2026 (USD MILLION)
6.5.2 ANIMAL IMMUNOHISTOCHEMISTRY KITS
6.5.2.1 Increasing preclinical drug testing to drive market growth
TABLE 112 IMMUNOHISTOCHEMISTRY MARKET FOR ANIMAL IMMUNOHISTOCHEMISTRY KITS, BY REGION, 2019-2026 (USD MILLION)

7 IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION (Page No. - 136)
7.1 INTRODUCTION
TABLE 113 IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
7.2 DIAGNOSTIC APPLICATIONS
TABLE 114 IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
TABLE 115 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 116 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 117 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 118 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
TABLE 119 IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
7.2.1 CANCER
7.2.1.1 Growing use of IHC tests for cancer diagnostics to fuel market growth
TABLE 120 COMMON CANCER MARKERS FOR IMMUNOHISTOCHEMICAL DIAGNOSIS
TABLE 121 IMMUNOHISTOCHEMISTRY MARKET FOR CANCER, BY REGION, 2019-2026 (USD MILLION)
TABLE 122 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR CANCER, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 123 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR CANCER, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 124 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR CANCER, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 125 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR CANCER, BY REGION, 2019-2026 (USD MILLION)
7.2.2 INFECTIOUS DISEASES
7.2.2.1 Growing prevalence of infectious diseases and rising awareness of early diagnosis to propel market growth
TABLE 126 COMMON INFECTIOUS DISEASE MARKERS/ANTIGENS FOR IMMUNOHISTOCHEMICAL DIAGNOSIS
TABLE 127 IMMUNOHISTOCHEMISTRY MARKET FOR INFECTIOUS DISEASES, BY REGION, 2019-2026 (USD MILLION)
TABLE 128 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 129 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 130 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 131 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR INFECTIOUS DISEASES, BY REGION, 2019-2026 (USD MILLION)
7.2.3 NEPHROLOGICAL DISEASES
7.2.3.1 Wide application of IHC in transplant rejection expected to support market growth
TABLE 132 IMMUNOHISTOCHEMISTRY MARKET FOR NEPHROLOGICAL DISEASES, BY REGION, 2019-2026 (USD MILLION)
TABLE 133 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 134 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 135 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 136 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR NEPHROLOGICAL DISEASES, BY REGION, 2019-2026 (USD MILLION)
7.2.4 AUTOIMMUNE DISEASES
7.2.4.1 Availability of numerous primary antibodies and rapid processing of results makes IHC a favorable diagnostic approach
TABLE 137 IMMUNOHISTOCHEMISTRY MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2019-2026 (USD MILLION)
TABLE 138 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 139 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 140 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 141 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2019-2026 (USD MILLION)
7.2.5 NEUROLOGICAL DISEASES
7.2.5.1 Increasing global burden of neurological diseases to propel market growth
TABLE 142 COMMON IMMUNOHISTOCHEMISTRY MARKERS FOR CENTRAL NERVOUS SYSTEM
TABLE 143 IMMUNOHISTOCHEMISTRY MARKET FOR NEUROLOGICAL DISEASES, BY REGION, 2019-2026 (USD MILLION)
TABLE 144 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 145 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 146 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 147 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR NEUROLOGICAL DISEASES, BY REGION, 2019-2026 (USD MILLION)
7.2.6 OTHER DISEASES
TABLE 148 IMMUNOHISTOCHEMISTRY MARKET FOR OTHER DISEASES, BY REGION, 2019-2026 (USD MILLION)
TABLE 149 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 150 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 151 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 152 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER DISEASES, BY REGION, 2019-2026 (USD MILLION)
7.3 RESEARCH APPLICATIONS
TABLE 153 IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
TABLE 154 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 155 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 156 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 157 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
TABLE 158 IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
7.3.1 DRUG DEVELOPMENT & TESTING
7.3.1.1 Quantitative image analysis makes IHC techniques ideal for drug testing
TABLE 159 IMMUNOHISTOCHEMISTRY MARKET FOR DRUG DEVELOPMENT & TESTING, BY REGION, 2019-2026 (USD MILLION)
7.3.2 OTHER RESEARCH APPLICATIONS
TABLE 160 IMMUNOHISTOCHEMISTRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
7.4 FORENSIC APPLICATIONS
TABLE 161 IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
TABLE 162 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 163 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 164 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 165 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)

8 IMMUNOHISTOCHEMISTRY MARKET, BY END USER (Page No. - 161)
8.1 INTRODUCTION
TABLE 166 IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
8.2 HOSPITALS & DIAGNOSTIC LABORATORIES
8.2.1 INCREASING INCIDENCE OF CANCER AND INFECTIOUS DISEASES TO INCREASE TESTING VOLUME IN CLINICAL LABORATORIES
TABLE 167 IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2019-2026 (USD MILLION)
TABLE 168 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 169 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 170 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 171 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2019-2026 (USD MILLION)
8.3 ACADEMIC & RESEARCH INSTITUTES
8.3.1 INCREASING USE OF IHC TESTS FOR DRUG DEVELOPMENT AND DISEASES DIAGNOSIS TO SUPPORT MARKET GROWTH
TABLE 172 IMMUNOHISTOCHEMISTRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019-2026 (USD MILLION)
TABLE 173 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 174 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 175 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 176 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019-2026 (USD MILLION)
8.4 OTHER END USERS
TABLE 177 IMMUNOHISTOCHEMISTRY MARKET FOR OTHER END USERS, BY REGION, 2019-2026 (USD MILLION)
TABLE 178 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 179 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 180 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 181 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER END USERS, BY REGION, 2019-2026 (USD MILLION)

9 IMMUNOHISTOCHEMISTRY MARKET, BY REGION (Page No. - 169)
9.1 INTRODUCTION
FIGURE 30 IMMUNOHISTOCHEMISTRY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
TABLE 182 IMMUNOHISTOCHEMISTRY MARKET, BY REGION, 2019-2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 31 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET SNAPSHOT
TABLE 183 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 184 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 185 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
TABLE 186 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 187 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
TABLE 188 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 189 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
TABLE 190 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
9.2.1 US
9.2.1.1 US is largest country-level market for immunohistochemistry
TABLE 191 RECENT DEVELOPMENTS IN US IHC MARKET
TABLE 192 US: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 193 US: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
TABLE 194 US: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 195 US: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
TABLE 196 US: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 197 US: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
TABLE 198 US: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Increasing cancer cases in Canada to propel market growth
TABLE 199 CANADA: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 200 CANADA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
TABLE 201 CANADA: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 202 CANADA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
TABLE 203 CANADA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 204 CANADA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
TABLE 205 CANADA: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
9.3 EUROPE
TABLE 206 RECENT DEVELOPMENTS IN EUROPEAN IHC MARKET
TABLE 207 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 208 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 209 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
TABLE 210 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 211 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
TABLE 212 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 213 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
TABLE 214 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany to dominate European IHC market
TABLE 215 GERMANY: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 216 GERMANY: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
TABLE 217 GERMANY: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 218 GERMANY: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
TABLE 219 GERMANY: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 220 GERMANY: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
TABLE 221 GERMANY: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
9.3.2 FRANCE
9.3.2.1 Increasing use of IHC in cancer diagnosis and research to drive market growth
TABLE 222 FRANCE: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 223 FRANCE: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
TABLE 224 FRANCE: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 225 FRANCE: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
TABLE 226 FRANCE: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 227 FRANCE: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
TABLE 228 FRANCE: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
9.3.3 UK
9.3.3.1 Increasing number of cancer research studies to support market growth
TABLE 229 UK: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 230 UK: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
TABLE 231 UK: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 232 UK: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
TABLE 233 UK: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 234 UK: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
TABLE 235 UK: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 High incidence of cancer and rising geriatric population to support market growth in Italy
TABLE 236 ITALY: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 237 ITALY: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
TABLE 238 ITALY: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 239 ITALY: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
TABLE 240 ITALY: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 241 ITALY: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
TABLE 242 ITALY: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Increasing demand for personalized medicine will drive demand for IHC tests to find potential biomarkers
TABLE 243 SPAIN: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 244 SPAIN: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
TABLE 245 SPAIN: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 246 SPAIN: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
TABLE 247 SPAIN: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 248 SPAIN: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
TABLE 249 SPAIN: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 250 ROE: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 251 ROE: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
TABLE 252 ROE: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 253 ROE: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
TABLE 254 ROE: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 255 ROE: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
TABLE 256 ROE: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 32 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET SNAPSHOT
TABLE 257 RECENT DEVELOPMENTS IN ASIA PACIFIC IHC MARKET
TABLE 258 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 259 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 260 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
TABLE 261 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 262 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
TABLE 263 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 264 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
TABLE 265 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Japan to dominate Asia Pacific immunohistochemistry market
TABLE 266 JAPAN: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 267 JAPAN: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
TABLE 268 JAPAN: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 269 JAPAN: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
TABLE 270 JAPAN: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 271 JAPAN: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
TABLE 272 JAPAN: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
9.4.2 CHINA
9.4.2.1 China to register highest growth during forecast period
TABLE 273 CHINA: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 274 CHINA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
TABLE 275 CHINA: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 276 CHINA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
TABLE 277 CHINA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 278 CHINA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
TABLE 279 CHINA: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 India is key destination for high-end pathology and diagnostic services
TABLE 280 INDIA: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 281 INDIA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
TABLE 282 INDIA: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 283 INDIA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
TABLE 284 INDIA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 285 INDIA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
TABLE 286 INDIA: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 287 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 288 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
TABLE 289 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 290 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
TABLE 291 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 292 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
TABLE 293 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
9.5 REST OF THE WORLD
TABLE 294 ROW: IMMUNOHISTOCHEMISTRY MARKET, BY REGION, 2019-2026 (USD MILLION)
TABLE 295 ROW: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 296 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
TABLE 297 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 298 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
TABLE 299 ROW: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 300 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
TABLE 301 ROW: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
9.5.1 LATIN AMERICA
9.5.1.1 Increasing incidence of cancer in Latin America driving market growth
TABLE 302 LATAM: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 303 LATAM: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
TABLE 304 LATAM: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 305 LATAM: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
TABLE 306 LATAM: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 307 LATAM: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
TABLE 308 LATAM: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
9.5.2 MIDDLE EAST AND AFRICA
9.5.2.1 Government initiatives focused on boosting healthcare infrastructure development to drive market growth
TABLE 309 MEA: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
TABLE 310 MEA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
TABLE 311 MEA: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
TABLE 312 MEA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
TABLE 313 MEA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
TABLE 314 MEA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
TABLE 315 MEA: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE (Page No. - 226)
10.1 OVERVIEW
10.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
FIGURE 33 KEY PLAYERS STRATEGIES IN IMMUNOHISTOCHEMISTRY MARKET, 2019- 2021
10.3 MARKET SHARE ANALYSIS
FIGURE 34 IMMUNOHISTOCHEMISTRY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
10.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 35 TOP MARKET PLAYERS DOMINATED IMMUNOHISTOCHEMISTRY MARKET FOR PAST 5 YEARS
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE
10.5.4 EMERGING COMPANIES
FIGURE 36 IMMUNOHISTOCHEMISTRY MARKET: COMPANY EVALUATION QUADRANT, 2020
10.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 37 IMMUNOHISTOCHEMISTRY MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
10.7 COMPANY PRODUCT FOOTPRINT
TABLE 316 PRODUCT PORTFOLIO ANALYSIS: IMMUNOHISTOCHEMISTRY MARKET (2020)
10.8 COMPANY GEOGRAPHIC FOOTPRINT
TABLE 317 GEOGRAPHIC REVENUE MIX: IMMUNOHISTOCHEMISTRY MARKET (2020)
10.9 COMPETITIVE SCENARIO
10.9.1 IMMUNOHISTOCHEMISTRY MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2019-MARCH 2021
10.9.2 IMMUNOHISTOCHEMISTRY MARKET: DEALS, JANUARY 2019-MARCH 2021
10.9.3 IMMUNOHISTOCHEMISTRY MARKET: OTHER DEVELOPMENTS, JANUARY 2019-MARCH 2021

11 COMPANY PROFILES (Page No. - 240)
11.1 KEY COMPANIES
(Business overview, Products and Services offered, Recent developments, MNM view)*
11.1.1 F. HOFFMANN-LA ROCHE AG
TABLE 318 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW
FIGURE 38 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2020)
11.1.2 DANAHER CORPORATION
TABLE 319 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
11.1.3 AGILENT TECHNOLOGIES, INC.
TABLE 320 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
FIGURE 40 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2020)
11.1.4 MERCK KGAA
TABLE 321 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2020)
11.1.5 BIO-RAD LABORATORIES, INC.
TABLE 322 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 42 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2020)
11.1.6 BIO-TECHNE CORPORATION
TABLE 323 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW
FIGURE 43 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2020)
11.1.7 ABCAM PLC
TABLE 324 ABCAM PLC: BUSINESS OVERVIEW
FIGURE 44 ABCAM PLC: COMPANY SNAPSHOT (2020)
11.1.8 BECTON, DICKINSON AND COMPANY
TABLE 325 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 45 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
11.1.9 PERKINELMER, INC.
TABLE 326 PERKINELMER, INC.: BUSINESS OVERVIEW
FIGURE 46 PERKINELMER, INC.: COMPANY SNAPSHOT (2020)
11.1.10 TAKARA BIO, INC.
TABLE 327 TAKARA BIO, INC.: BUSINESS OVERVIEW
FIGURE 47 TAKARA BIO, INC.: COMPANY SNAPSHOT (2020)
11.1.11 THERMO FISHER SCIENTIFIC, INC.
TABLE 328 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
FIGURE 48 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2020)
11.1.12 PHC HOLDINGS CORPORATION
TABLE 329 PHC HOLDINGS CORPORATION: BUSINESS OVERVIEW
11.1.13 CELL SIGNALING TECHNOLOGY, INC.
TABLE 330 CELL SIGNALING TECHNOLOGY, INC.: BUSINESS OVERVIEW
11.1.14 BIO SB, INC.
TABLE 331 BIO SB, INC.: BUSINESS OVERVIEW
11.1.15 MILTENYI BIOTEC
TABLE 332 MILTENYI BIOTEC: BUSINESS OVERVIEW
11.1.16 CANDOR BIOSCIENCE GMBH
TABLE 333 CANDOR BIOSCIENCE GMBH: BUSINESS OVERVIEW
11.1.17 SAKURA FINETEK JAPAN CO., LTD.
TABLE 334 SAKURA FINETEK JAPAN CO., LTD.: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 EAGLE BIOSCIENCES, INC.
TABLE 335 EAGLE BIOSCIENCES, INC.: COMPANY OVERVIEW
11.2.2 BIOCARE MEDICAL, LLC
TABLE 336 BIOCARE MEDICAL, LLC: COMPANY OVERVIEW
11.2.3 ELABSCIENCE, INC.
TABLE 337 ELABSCIENCE, INC.: COMPANY OVERVIEW
11.2.4 BIO-GENEX LABORATORIES
TABLE 338 BIO-GENEX LABORATORIES: COMPANY OVERVIEW
11.2.5 DIAGNOSTIC BIOSYSTEMS, INC.
TABLE 339 DIAGNOSTIC BIOSYSTEMS, INC.: COMPANY OVERVIEW
11.2.6 BIOVISION, INC.
TABLE 340 BIOVISION, INC.: COMPANY OVERVIEW
11.2.7 ROCKLAND IMMUNOCHEMICALS, INC.
TABLE 341 ROCKLAND IMMUNOCHEMICALS, INC.: COMPANY OVERVIEW
11.2.8 GENEMED BIOTECHNOLOGIES, INC.
TABLE 342 GENEMED BIOTECHNOLOGIES, INC.: COMPANY OVERVIEW
*Business overview, Products and Services offered, Recent developments, MNM view might not be captured in case of unlisted companies.

12 APPENDIX (Page No. - 346)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS